These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 26255683

  • 21. Cardiovascular disease risk prediction by the American College of Cardiology (ACC)/American Heart Association (AHA) Atherosclerotic Cardiovascular Disease (ASCVD) risk score among HIV-infected patients in sub-Saharan Africa.
    Mosepele M, Hemphill LC, Palai T, Nkele I, Bennett K, Lockman S, Triant VA.
    PLoS One; 2017; 12(2):e0172897. PubMed ID: 28235058
    [Abstract] [Full Text] [Related]

  • 22. Accuracy of the Atherosclerotic Cardiovascular Risk Equation in a Large Contemporary, Multiethnic Population.
    Rana JS, Tabada GH, Solomon MD, Lo JC, Jaffe MG, Sung SH, Ballantyne CM, Go AS.
    J Am Coll Cardiol; 2016 May 10; 67(18):2118-2130. PubMed ID: 27151343
    [Abstract] [Full Text] [Related]

  • 23. Evaluating a Simple Approach to Identify Adults Meeting the 2018 AHA/ACC Cholesterol Guideline Definition of Very High Risk for Atherosclerotic Cardiovascular Disease.
    Muntner P, Orroth KK, Mues KE, Exter J, Shannon ED, Zaha R, Rosenson RS, Jackson EA.
    Cardiovasc Drugs Ther; 2022 Jun 10; 36(3):475-481. PubMed ID: 33661432
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Integrated approach of brachial-ankle pulse wave velocity and cardiovascular risk scores for predicting the risk of cardiovascular events.
    Kim HM, Rhee TM, Kim HL.
    PLoS One; 2022 Jun 10; 17(4):e0267614. PubMed ID: 35476644
    [Abstract] [Full Text] [Related]

  • 27. Subclinical Atherosclerosis, Statin Eligibility, and Outcomes in African American Individuals: The Jackson Heart Study.
    Shah RV, Spahillari A, Mwasongwe S, Carr JJ, Terry JG, Mentz RJ, Addison D, Hoffmann U, Reis J, Freedman JE, Lima JAC, Correa A, Murthy VL.
    JAMA Cardiol; 2017 Jun 01; 2(6):644-652. PubMed ID: 28315622
    [Abstract] [Full Text] [Related]

  • 28. Predictive validity of the ACC/AHA pooled cohort equations in predicting residual-specific mortality in a national prospective cohort study of adults in the United States.
    Edwards MK, Addoh O, Loprinzi PD.
    Postgrad Med; 2016 Nov 01; 128(8):865-868. PubMed ID: 27701986
    [Abstract] [Full Text] [Related]

  • 29. Comparative performance of the two pooled cohort equations for predicting atherosclerotic cardiovascular disease.
    Campos-Staffico AM, Cordwin D, Murthy VL, Dorsch MP, Luzum JA.
    Atherosclerosis; 2021 Oct 01; 334():23-29. PubMed ID: 34461391
    [Abstract] [Full Text] [Related]

  • 30. The new pooled cohort equations risk calculator.
    Preiss D, Kristensen SL.
    Can J Cardiol; 2015 May 01; 31(5):613-9. PubMed ID: 25843167
    [Abstract] [Full Text] [Related]

  • 31. Recalibration of the ACC/AHA Risk Score in Two Population-Based German Cohorts.
    de Las Heras Gala T, Geisel MH, Peters A, Thorand B, Baumert J, Lehmann N, Jöckel KH, Moebus S, Erbel R, Meisinger C, Mahabadi AA, Koenig W, KORA Study Group and the Heinz Nixdorf Recall Study Group.
    PLoS One; 2016 May 01; 11(10):e0164688. PubMed ID: 27732641
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Risk Prediction Models for Atherosclerotic Cardiovascular Disease in Patients with Chronic Kidney Disease: The CRIC Study.
    Bundy JD, Rahman M, Matsushita K, Jaeger BC, Cohen JB, Chen J, Deo R, Dobre MA, Feldman HI, Flack J, Kallem RR, Lash JP, Seliger S, Shafi T, Weiner SJ, Wolf M, Yang W, Allen NB, Bansal N, He J, the CRIC Study Investigators .
    J Am Soc Nephrol; 2022 Mar 01; 33(3):601-611. PubMed ID: 35145041
    [Abstract] [Full Text] [Related]

  • 36. Statin Use in Primary Prevention of Atherosclerotic Cardiovascular Disease According to 5 Major Guidelines for Sensitivity, Specificity, and Number Needed to Treat.
    Mortensen MB, Nordestgaard BG.
    JAMA Cardiol; 2019 Nov 01; 4(11):1131-1138. PubMed ID: 31577339
    [Abstract] [Full Text] [Related]

  • 37. Validation of the pooled cohort risk score in an Asian population - a retrospective cohort study.
    Chia YC, Lim HM, Ching SM.
    BMC Cardiovasc Disord; 2014 Nov 20; 14():163. PubMed ID: 25410585
    [Abstract] [Full Text] [Related]

  • 38. External validation of pooled cohort equations using systolic blood pressure intervention trial data.
    Kuragaichi T, Kataoka Y, Miyakoshi C, Miyamoto T, Sato Y.
    BMC Res Notes; 2019 May 14; 12(1):271. PubMed ID: 31088530
    [Abstract] [Full Text] [Related]

  • 39. Estimation of Atherosclerotic Cardiovascular Disease Risk Among Patients in the Veterans Affairs Health Care System.
    Vassy JL, Lu B, Ho YL, Galloway A, Raghavan S, Honerlaw J, Tarko L, Russo J, Qazi S, Orkaby AR, Tanukonda V, Djousse L, Gaziano JM, Gagnon DR, Cho K, Wilson PWF.
    JAMA Netw Open; 2020 Jul 01; 3(7):e208236. PubMed ID: 32662843
    [Abstract] [Full Text] [Related]

  • 40. Cardiovascular Risk Prediction Functions Underestimate Risk in HIV Infection.
    Triant VA, Perez J, Regan S, Massaro JM, Meigs JB, Grinspoon SK, D'Agostino RB.
    Circulation; 2018 May 22; 137(21):2203-2214. PubMed ID: 29444987
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.